Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts Progenics Pharmaceuticals (PGNX) at Overweight
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
-
Cantor Fitzgerald Reiterates a 'Buy' on Salix Pharmaceuticals (SLXP); Is Relistor Still in Play?
-
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Relistor News Provides Upside To Our Estimates
